Bisphosphonate-induced avascular osteonecrosis of the mandible associated with a common thrombophilic mutation in the prothrombin gene.
Vairaktaris
Eleftherios
E
Department of Oral and Maxillofacial Surgery, University of Athens Medical School, Attikon Hospital, Athens, Greece. lvairakt@med.uoa.gr
Vassiliou
Stavros
S
Avgoustidis
Dimitrios
D
Stathopoulos
Panagiotis
P
Toyoshima
Takeshi
T
Yapijakis
Christos
C
D000368:Aged; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy / Q000556:secondary; D001943:Breast Neoplasms / Q000473:pathology; D003646:Debridement; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008334:Mandible / Q000098:blood supply; D008336:Mandibular Diseases / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D009154:Mutation; D010020:Osteonecrosis / Q000139:chemically induced / Q000150:complications* / Q000601:surgery; D010375:Pedigree; D053657:Platelet-Rich Plasma; D011516:Prothrombin / Q000235:genetics*; D019851:Thrombophilia / Q000150:complications / Q000235:genetics*; D014081:Tooth Extraction / Q000009:adverse effects
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D011516:Prothrombin